EU approves second COVID-19 vaccineFollowing a recommendation by the European Medicines Agency (EMA), the European Commission has approved a second vaccine against the novel coronavirus SARS-CoV-2. more ➔
Angelini Pharma to take over Arvelle Thera...Italian Angelini Pharma and Swiss CNS disease specialist Arvelle Therapeutics have entered into a definitive merger agreement. more ➔
COVID-19 test gives results within minutesUniversity of Birmingham researchers have invented a COVID-19 RNA test that reduces testing time from 30 minutes to under five, and delivers accurate results. more ➔
Merry Christmas and a Happy New YearDear readers,We wish all visitors to our news page a peaceful and healthy New Year and a successful start to the New Year. Stay healthy! We will be back with the latest news from 4 January.Best … more ➔
EMA greenlights BioNtech’s COVID-19...Following a rapid FDA approval, the European drug authority EMA has recommended to conditionally approve BioNTechs mRNA vaccine BNT162b2 in the EU. more ➔
European Circular Bioeconomy Fund growingOnly two and a half months after its launch, the EU bioecocomy venture capital fund ECBF has doubled the volume of its first closing. more ➔
Novo Holdings creates HemabDanish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies. more ➔
Biotech companies launch Biotech AustriaAustria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria. more ➔
How microplastic particles get into the bo... Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells. more ➔
Centogene and Anylam launch clinical progr...Diagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis. more ➔
